2.0
26 Sept 2023
Anonymous employee
Current employee
Recommend
CEO approval
Business outlook
Pros
Great chance for young graduates to start the career
Cons
Company has no proper pipeline, MT makes their decision purely base on business without considering scientific risks (which is why they failed their previous clinical projects).